Our results indicate that TTFields not only altered diverse cellular responses TP53-dependently or TP53-independently, but there may be differences in the underlying mechanisms and responses depending on the TP53 status and would closely associated with other prognostic factors in GBM, as demonstrated by Schneiderman et al.19. The gene discussed is TP53; the disease is glioblastoma.